Skip to main content
倍益康 logo

倍益康 — Investor Relations & Filings

Ticker · 920199 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2023-04-16 AGM Information
Country CN China
Listing Beijing Stock Exchange 920199

About 倍益康

https://www.qlbeoka.com/

Beiyikang focuses on the research, development, and manufacturing of rehabilitation and physical therapy equipment. The company integrates professional medical technology with consumer-oriented health solutions. Its product lineup features percussive massage devices, oxygen concentrators, blood pressure monitors, and specialized physical therapy instruments for pain relief and muscle recovery. By utilizing advanced manufacturing processes and technological innovation, Beiyikang delivers products for sports recovery, clinical rehabilitation, and personal health management. The company prioritizes the incorporation of smart technology into its hardware to improve therapeutic outcomes and user experience across its range of recovery and wellness devices.

Recent filings

Filing Released Lang Actions
2022 年年度报告业绩说明会预告公告
AGM Information Classification · 95% confidence The document is a notice announcing a scheduled performance explanation meeting related to the company's 2022 Annual Report. It references the 2022 Annual Report already published (announcement number 2023-028) and provides details about the upcoming investor meeting to discuss the report. The document is short (1026 characters) and does not contain actual financial data or the report itself, but rather an announcement about the meeting to explain the annual report results. According to the 'Menu vs Meal' rule, this is an announcement related to a report, not the report itself. Therefore, the appropriate classification is AGM Information (AGM-R), as it is a notice about an annual report performance explanation meeting (a type of AGM-related event).
2023-04-16 Chinese
对外投资设立控股子公司的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's external investment to establish a controlling subsidiary. It details the investment overview, approval status, investment parties, and the purpose and risks of the investment. It explicitly states that the investment does not constitute a major asset restructuring or related party transaction and includes financial figures related to the investment. The document is relatively short (2173 characters) and serves as a formal public announcement of a corporate action rather than a detailed financial report or management discussion. It does not contain financial statements, audit opinions, or detailed financial analysis. Therefore, it fits best into the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as establishing subsidiaries through investment.
2023-04-09 Chinese
信永中和会计师事务所（特殊普通合伙）关于四川千里倍益康医疗科技股份有限公司2022年度募集资金年度存放与使用情况鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "募集资金年度存放与使用情况鉴证报告" which translates to "Annual Verification Report on the Storage and Use of Raised Funds" for the year 2022. It includes detailed information about the amount of funds raised, their usage during the year, balances, and compliance with regulatory requirements. The report is prepared by an accounting firm (ShineWing) and includes verification opinions, which indicates it is a specialized audit or assurance report related to the use of capital raised by the company. This type of document is not a full Annual Report (10-K), nor is it a general Audit Report (AR) of financial statements, but a specific audit/verification report on the use of raised funds. It is not an announcement or a brief summary but a substantive report with detailed financial data and verification. Therefore, the most appropriate classification is Audit Report / Information (AR).
2023-04-06 Chinese
2022年年度股东大会通知公告（提供网络投票）
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2022 Annual General Meeting (AGM) of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It includes information about the meeting date, voting methods (including online voting), agenda items such as the 2022 board work report, independent director report, supervisory board report, 2022 annual report and summary, financial reports, profit distribution plan, appointment of auditors, and remuneration plans. The document is a formal announcement inviting shareholders to attend the AGM and vote on these matters. It does not contain the actual annual report or financial statements but references where these can be found. The document length is about 4568 characters, which is consistent with a detailed AGM notice rather than the full annual report. Therefore, this document fits the category of AGM Information (AGM-R).
2023-04-06 Chinese
东莞证券股份有限公司关于四川千里倍益康医疗科技股份有限公司治理专项自查及规范活动相关情况的专项核查报告
Audit Report / Information Classification · 95% confidence The document is titled as a "专项核查报告" (special inspection report) issued by Dongguan Securities Co., Ltd. as the sponsor and continuous supervision institution for Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It is a detailed governance special self-inspection and regulatory activity report for the year 2022. The content includes detailed descriptions of the company's governance, internal control systems, board and management qualifications and activities, decision-making procedures, and checks on financial irregularities such as fund occupation, illegal guarantees, and insider trading. It is a standalone audit-related report focusing on governance and compliance, not a full annual report or financial statement. It does not contain quarterly or annual financial statements or earnings highlights, nor is it a brief announcement or presentation. Therefore, it fits best under the category of Audit Report / Information (AR). The document length is about 4989 characters, which is sufficient for a detailed report rather than a brief announcement. FY 2022
2023-04-06 Chinese
第三届监事会第九次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details the meeting date, attendance, and the approval of various reports and proposals including the 2022 Supervisory Board Work Report, 2022 Annual Report and Summary, 2022 Financial Final Report, 2023 Financial Budget Report, 2022 Profit Distribution Plan, reappointment of the accounting firm, remuneration plan for 2023, special report on raised funds usage, non-operating fund occupation report, governance self-inspection report, and internal control self-evaluation report. The document repeatedly states that these reports have been or will be disclosed on the Beijing Stock Exchange information platform with specific announcement numbers, indicating that this document itself is not the reports but a meeting resolution announcing the approval of these reports and proposals. The document length is 4174 characters, which is relatively short and mainly serves as an announcement of meeting resolutions rather than containing the full reports or detailed financial data. Therefore, according to the "Menu vs Meal" rule, this document is best classified as a Regulatory Filing (RNS) because it is a formal announcement of meeting resolutions and approvals, not the reports themselves.
2023-04-06 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.